NephroGenex: A Significant Unmet Medical Need

By: via Benzinga
NephroGenex, Inc. (NASDAQ: NRX) has seen a 44.76 percent decline in its share price over the past six months. Yi Chen of HC ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.